Labforward

Private
BerlinEnterprise Software

Last Round

Series B

May 4, 2021

Total Funding Raised

$10.35M

Company Overview

Labforward is a SaaS company which develops a digital platform with products that include an electronic lab notebook (ELN), an inventory management system, and a laboratory automation and execution system.

Sector

Enterprise Software

Verticals

Vertical SaaS, Biotechnology, Workflow Automation, Data Integration, NLP & Conversational AI

Business Model

B2B

Customer Profile

Subscription SaaS, Freemium, Services & Consulting

AI Layer

Application

Keywords

electronic lab notebookELNlab informaticsinstrument integrationconnected laboratorylab execution systemLESlab automationAI lab assistantdigital lab notebooklab inventory managementvoice-powered lab assistantsmart labLIMSon-premise deploymentGLP compliance

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Labforward Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Labforward Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BMay 4, 2021
Series ASep 1, 2015
SeedOct 18, 2013

Labforward Investors

Notable investors and investment history

InvestorRounds
IBB VenturesSeries B
Vogel VenturesSeed, Series A
Peppermint Venture PartnersSeries B
IBB BeteiligungsgesellschaftSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 2, 2026

    Added Daiichi Sankyo Co., Ltd. from the Pharmaceuticals industry.

  • Jan 2, 2026

    Added Ceva, an animal health company, as a customer.

Labforward Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Labforward Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Labforward's valuation, stock price, and market status.

Firmographic Details

HeadquartersBerlin
Year Founded2013
Last FundingMay 4, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.